News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
04
2023
-
12
Jiang Hongsheng, Chairman of Dialogue Keyuan Pharmaceuticals and President of Liino Pharmaceuticals: R & D is the core of enterprise development!
Classification：
News
Corporate News
Zhonghong Network, Shandong, November 15Recently, Shandong Keyuan Pharmaceutical Co., Ltd. (hereinafter referred to as Keyuan Pharmaceutical) and Beijing Nokangda Pharmaceutical Technology Co., Ltd. (hereinafter referred to as Nokangda) held an equity cooperation agreement signing ceremony.
Keyuan PharmaceuticalIt is a leading enterprise in the domestic chemical raw material drug market segment,This year, Keyuan Pharmaceutical successfully listed on the GEM.It marks that the company has entered a high-speed development stage of capital assistance. jiang hongsheng, chairman of keyuan pharmaceutical and president of lino pharmaceutical, said in an interview that the strong alliance with noconda,Keyuan Pharmaceutical's research and development capabilities will be greatly enhanced, and its core competitive advantages will be further highlighted,Strong support for the achievement of the company's strategic objectives.
The following is an interview with Jiang Hongsheng:
Reporter: Could you please talk about Keyuan Pharmaceutical's cooperation with Nokangda in the past and why it chose to cooperate with Nokangda this time?
jiang hongsheng:The cooperation between Keyuan Pharmaceutical, Reno Pharmaceutical and Nokanda began in April. The two sides have a high degree of agreement in corporate culture and management concepts,The technology research and development level, efficient transformation ability and Keyuan Pharmaceutical, lino pharmaceutical's strong market base, production and operation capacity can form a complementary advantage.
It has been exactly ten years since the establishment of Nokangda Pharmaceuticals. Their achievements in the past ten years are obvious to all. Chairman Chen Peng and General Manager Tao Xiumei have brought out an excellent team. This is their advantage. We are very optimistic about the development of Nokangda Pharmaceuticals. Prospects, willing to develop deeper cooperation with Nokangda.
Reporter: In the digital age, how do you understand the combination of digital intelligence and the pharmaceutical industry?
jiang hongsheng:In my opinion, the combination of digital intelligence and pharmaceutical industry refers to the use of digital technology and data analysis to improve all aspects of the pharmaceutical industry, including research and development, production, sales and service. This combination can bring many benefits, suchImprove efficiency, reduce costs, improve quality of care and enhance patient experienceWait.
First of all,In the field of research and development, digital intelligence technology can help researchers analyze large amounts of medical data more quickly.Discover new drug targets and treatments.
Secondly,In the production process, digital intelligence technology can improve the quality control and production efficiency of drugs.. Through the Internet of Things and sensor technology, the operating status and environmental conditions of production equipment can be monitored in real time, and problems can be found and adjusted in time. At the same time, the use of big data analysis and forecasting models can optimize production planning and supply chain management, reduce inventory and waste, and improve production efficiency and responsiveness.
Again,In sales and marketing, digital intelligence technology can help companies better understand market needs and consumer behavior.Through data analysis and artificial intelligence technology, we can mine consumer preferences and needs, accurately locate target customers, and provide personalized products and services. At the same time, the use of the Internet and mobile applications can achieve seamless connection between online and offline, and provide more convenient drug purchase and health management services.
And finally,In terms of medical services, digital intelligence technology can improve medical quality and patient experience.Through the digitization of electronic medical records and health records, the sharing and intercommunication of medical information can be realized, and the diagnosis and treatment effect of doctors can be improved. At the same time, the use of telemedicine and mobile health monitoring technology can achieve remote diagnosis and health management, convenient for patients to seek medical treatment and monitor the progress of the disease.
The combination of digital intelligence and the pharmaceutical industry can promote the innovation and development of the pharmaceutical industry, improve the quality and efficiency of medical care, provide better protection for people's health, and truly benefit mankind.
Reporter: Through this in-depth cooperation with Nokangda, the company can obtain solid technical support and further enhance the company's R & D strength and competitiveness. Please talk to Mr. Jiang. Does Keyuan Pharmaceutical have any plans to continuously improve the competitiveness of the enterprise?
jiang hongsheng:R & D is the core of the enterprise,We recruit international talents in R & D talents. Dr. Kishor, the leader of the R & D center, is from an international pharmaceutical enterprise in India and has won honors such as high-end foreign talents in Quancheng. The company's R & D center is an enterprise technology center in Shandong Province and a post-doctoral innovation practice base in Jinan. Linuo Pharmaceutical Research Institute andShanghai WuXi AppTecBeijing Sunshine Novo, Beijing Novo, Chongqing Boten Pharmaceutical, Tianjin Kelaiying Pharmaceutical, Shandong University and other research and development companies and universities have established long-term and stable cooperative relations,Jointly carry out the research of scientific and technological projects, the transformation of scientific and technological achievements, and the training of scientific and technological talents in a rapid and high-quality manner.It has laid a solid technical foundation for the company's long-term sustainable development.
In addition to research and development,Smart manufacturing and cultural marketing are also very important for the pharmaceutical industry.The new projects of Keyuan Pharmaceutical API are high-end intelligent manufacturing plants that integrate safety, environmental protection, quality, and cost in accordance with the continuous flow design, digitalization and information that currently represent the latest technology., Environmentally friendly smart API industrial park.
Cultural marketing is the soft power of enterprises, Keyuan Pharmaceutical, lino pharmaceutical identified.Accurate Five Forces Marketing Model, empowering with product systems and competitive strategies.Competitiveness; Enhanced with new products, new processes, new materials and new projectsinnovation powerWith the international quality system, the global pharmaceutical registration to build.Quality forceTo flexible customized production system, international OEM cooperation business to enhance.Ability to deliver; Promote a green, ecological, low-carbon and environmentally friendly national 4A tourism parksustainable development.
Related news
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China
